176 related articles for article (PubMed ID: 8479077)
1. [Clinical implications of chromosome analysis in myelodysplastic syndrome].
Ohyashiki K; Toyama K
Rinsho Ketsueki; 1993 Mar; 34(3):269-72. PubMed ID: 8479077
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227
[TBL] [Abstract][Full Text] [Related]
3. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
4. [Cytogenetic study of 93 myelodysplastic syndromes].
Solé F; Woessner S; Florensa L; Pérez-Losada A; Acín P; Besses C; García-Eroles L; Sans-Sabrafen J
Med Clin (Barc); 1998 Jan; 110(3):94-8. PubMed ID: 9534140
[TBL] [Abstract][Full Text] [Related]
5. Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Czechoslovak MDS Cooperative Group.
Michalova K; Musilova J; Zemanova Z
Ann Genet; 1991; 34(3-4):212-8. PubMed ID: 1809229
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic evolution correlates with poor prognosis in myelodysplastic syndrome.
Wang H; Wang XQ; Xu XP; Lin GW
Cancer Genet Cytogenet; 2010 Jan; 196(2):159-66. PubMed ID: 20082852
[TBL] [Abstract][Full Text] [Related]
7. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
[TBL] [Abstract][Full Text] [Related]
8. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome].
Gritsaev SV; Martynkevich IS; Abdulkadyrov KM; Tiranova SA; Kakaĭ MP; Martynenko LS; Dziavgo LA
Ter Arkh; 2005; 77(7):22-7. PubMed ID: 16116904
[TBL] [Abstract][Full Text] [Related]
10. [Hematological study in 27 patients with myelodysplastic syndrome (MDS)].
Arai T; Taoka T; Yamaoka G; Kiuchi H; Kawanishi K
Rinsho Byori; 1993 Jan; 41(1):107-11. PubMed ID: 8355404
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
Panani AD; Roussos C
Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
[TBL] [Abstract][Full Text] [Related]
12. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
13. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
[TBL] [Abstract][Full Text] [Related]
14. Chromosomes in myelodysplastic syndrome: structural abnormalities of chromosome 11. Czechoslovak MDS Cooperative Group.
Musilova J; Michalova K; Jarosova M
Ann Genet; 1989; 32(1):43-6. PubMed ID: 2751248
[TBL] [Abstract][Full Text] [Related]
15. [Clonal chromosomal aberrations in patients with aplastic anemia at the disease onset and transformation].
Ol'shanskaia IuV; Mikhaĭlova EA; Domracheva EV; Udovichenko AI; Davidian IuR; Vodinskaia LA; Zakharova AV; Kokhno AV; Kaplanskaia IB; Tikhonova LIu; Tsvetaeva NV; Parovichnikova EN; Savchenko VG
Ter Arkh; 2006; 78(7):31-4, 36-7. PubMed ID: 16944748
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of cytogenetics in myelodysplastic syndromes.
Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Dambruoso I; Caresana M
Ann N Y Acad Sci; 2006 Nov; 1089():395-410. PubMed ID: 17261783
[TBL] [Abstract][Full Text] [Related]
17. Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution.
Bernasconi P; Klersy C; Boni M; Cavigliano PM; Giardini I; Rocca B; Zappatore R; Dambruoso I; Calvello C; Caresana M; Lazzarino M
Ann Hematol; 2010 Jun; 89(6):545-51. PubMed ID: 20217086
[TBL] [Abstract][Full Text] [Related]
18. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
[TBL] [Abstract][Full Text] [Related]
19. Sequential observation of clinical and karyotypic evolution in a patient with myelodysplastic syndrome.
Xue YQ; Guo Y; Lin BJ; Zhang GR; Lu DW; Wang MH; Gu YZ; Gong JX; Wang LX
Chin Med J (Engl); 1989 Sep; 102(9):689-94. PubMed ID: 2517082
[TBL] [Abstract][Full Text] [Related]
20. [Contemporary possibilities of prognosis in myelodysplastic syndromes].
Goździk J; Lewandowski K; Hansz J
Acta Haematol Pol; 1995; 26(2):129-38. PubMed ID: 7653217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
